{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:50:10Z","timestamp":1790419810959,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1038\/s10038-019-0604-6","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T09:12:35Z","timestamp":1556097155000},"page":"625-635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Effect of enzyme replacement therapy on the growth of patients with Morquio A"],"prefix":"10.1038","volume":"64","author":[{"given":"Caitlin","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Piechnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"604_CR1","first-page":"2091","volume-title":"Handbook of Growth and Growth Monitoring in Health and Disease","author":"Shunji Tomatsu","year":"2011","unstructured":"Tomatsu S, Monta\u00f1o AM, Oikawa H, Giugliani R, Harmatz P, Smith M, et al. Impairment of body growth in mucopolysaccharidoses. In: Preedy V. (ed.) Handbook of growth and growth monitoring in health and disease. New York, NY: Springer; 2012. p. 2091\u2013117."},{"key":"604_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgmr.2017.11.005","volume":"14","author":"C Doherty","year":"2018","unstructured":"Doherty C, Averill LW, Theroux M, Mackenzie WG, Pizarro C, Mason RW, et al. Natural history of Morquio A patient with tracheal obstruction from birth to death. Mol Genet Metab Rep. 2018;14:59\u201367.","journal-title":"Mol Genet Metab Rep"},{"key":"604_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgme.2006.05.012","volume":"89","author":"S Tomatsu","year":"2006","unstructured":"Tomatsu S, Monta\u00f1o AM, Lopez P, Trandafirescu G, Gutierrez MA, Oikawa H, et al. Determinant factors of spectrum of missense variants in mucopolysaccharidosis IVA gene. Mol Genet Metab. 2006;89:139\u201349.","journal-title":"Mol Genet Metab"},{"key":"604_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","volume":"146","author":"AM Monta\u00f1o","year":"2008","unstructured":"Monta\u00f1o AM, Tomatsu S, Brusius A, Smith M, Orii T. Growth charts for patients affected with Morquio A disease. Am J Med Genet Part A. 2008;146:1286\u201395.","journal-title":"Am J Med Genet Part A"},{"key":"604_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o AM, Tomatsu S, Gottesman GS, Smith M, Orii T. International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis. 2007;30:165\u201374.","journal-title":"J Inherit Metab Dis"},{"key":"604_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymgme.2013.06.008","volume":"110","author":"VC D\u0169ng","year":"2013","unstructured":"D\u0169ng VC, Tomatsu S, Monta\u00f1o AM, Gottesman G, Bober MB, Mackenzie W, et al. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels. Mol Genet Metab. 2013;110:129\u201338.","journal-title":"Mol Genet Metab"},{"key":"604_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","volume":"120","author":"S Khan","year":"2017","unstructured":"Khan S, Alm\u00e9ciga-D\u00edaz CJ, Sawamoto K, Mackenzie WG, Theroux MC, Pizarro C, et al. Mucopolysaccharidosis IVA and glycosaminoglycans. Mol Genet Metab. 2017;120:78\u201395.","journal-title":"Mol Genet Metab"},{"key":"604_CR8","unstructured":"Tomatsu S. Mucopolysaccharidosis Type IVA: clinical features, biochemistry, diagnosis, genetics, and treatment. Mucopolysaccharidoses update: (2 volume set) Ch. 12. New York: Nova Science Publishers; 2018. p. 235\u201371."},{"key":"604_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004390050641","volume":"101","author":"J Nelson","year":"1997","unstructured":"Nelson J. Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet. 1997 101:355\u20138.","journal-title":"Hum Genet"},{"key":"604_CR10","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","volume":"105","author":"DA Applegarth","year":"2000","unstructured":"Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996. Pediatrics. 2000;105:e10.","journal-title":"Pediatrics"},{"key":"604_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249\u201354.","journal-title":"JAMA"},{"key":"604_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet. 1999;105:151\u20136.","journal-title":"Hum Genet"},{"key":"604_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","volume":"12","author":"R Pinto","year":"2004","unstructured":"Pinto R, Caseiro C, Lemos M, Lopes L, Fontes A, Ribeiro H, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet. 2004;12:87\u201392.","journal-title":"Eur J Hum Genet"},{"key":"604_CR14","unstructured":"Khan S, Orii T, Giugliani R, et al. Epidemiology of mucopolysaccharidoses. In: Shunji Tomatsu, Christine Lavery, Roberto Giugliani, Paul Harmatz, Maurizio Scarpa, Grzegorz W\u0119grzyn and Tadao Orii (eds.) Mucopolysaccharidoses update, vol. 1, Ch. 12. New York: Nova Science Publishers; 2018. p. 21\u201345."},{"key":"604_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ymgme.2017.05.016","volume":"121","author":"SA Khan","year":"2017","unstructured":"Khan SA, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M, et al. Epidemiology of mucopolysaccharidoses. Mol Genet Metab. 2017;121:227\u201340.","journal-title":"Mol Genet Metab"},{"key":"604_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2018.03.004","volume":"124","author":"M Melbouci","year":"2018","unstructured":"Melbouci M, Mason RW, Suzuki Y, Fukao T, Orii T, Tomatsu S. Growth impairment in mucopolysaccharidoses. Mol Genet Metab. 2018;124:1\u201310.","journal-title":"Mol Genet Metab"},{"key":"604_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","volume":"110","author":"CJ Hendriksz","year":"2013","unstructured":"Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, et al. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab. 2013;110:54\u201364.","journal-title":"Mol Genet Metab"},{"key":"604_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2018.05.004","volume":"125","author":"H Peracha","year":"2018","unstructured":"Peracha H, Sawamoto K, Averill L, Kecskemethy H, Theroux M, Thacker M, et al. Molecular genetics and metabolism, special edition: diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Mol Genet Metab. 2018;125:18\u201337.","journal-title":"Mol Genet Metab"},{"key":"604_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ymgme.2015.09.007","volume":"117","author":"S Tomatsu","year":"2016","unstructured":"Tomatsu S, Averill LW, Sawamoto K, Mackenzie WG, Bober MB, Pizarro C, et al. Obstructive airway in Morquio A syndrome, the past, the present and the future. Mol Genet Metab. 2016;117:150\u20136.","journal-title":"Mol Genet Metab"},{"key":"604_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1651-2227.2009.01134.x","volume":"98","author":"A Ohashi","year":"2009","unstructured":"Ohashi A, Monta\u00f1o AM, Col\u00f3n JE, Oguma T, Luisiri A, Tomatsu S. Sacral dimple: incidental findings from newborn evaluation (Case Presentation). Acta Paediatr. 2009;98:768\u20139.","journal-title":"Acta Paediatr"},{"key":"604_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/138920111795542615","volume":"12","author":"S Tomatsu","year":"2011","unstructured":"Tomatsu S, Monta\u00f1o AM, Oikawa H, Smith M, Barrera L, Chinen Y, et al. Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol. 2011;12:931\u201345.","journal-title":"Curr Pharm Biotechnol"},{"key":"604_CR22","doi-asserted-by":"crossref","unstructured":"Tomatsu S, Giugliani R, Kubaski F, Kazuki S, Alm\u00e9ciga-D\u00edaz CJ, Barrera L, et al. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Dev Ther. 2015;9:1937.","DOI":"10.2147\/DDDT.S68562"},{"key":"604_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","volume":"3","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, et al. Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs. 2015;3:1279\u201390.","journal-title":"Expert Opin Orphan Drugs"},{"key":"604_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","volume":"117","author":"H Yabe","year":"2016","unstructured":"Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, et al. Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab. 2016;117:84\u201394.","journal-title":"Mol Genet Metab"},{"key":"604_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ymgmr.2013.11.002","volume":"1","author":"Y Chinen","year":"2014","unstructured":"Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA. Mol Genet Metab Rep. 2014;1:31\u201341.","journal-title":"Mol Genet Metab Rep"},{"key":"604_CR26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","volume":"37","author":"CJ Hendriksz","year":"2014","unstructured":"Hendriksz CJ, Burton B, Fleming TR, Harmatz P, Hughes D, Jones SA, et al. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis. 2014;37:979\u201390.","journal-title":"J Inherit Metab Dis"},{"key":"604_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","volume":"167","author":"JE Wraith","year":"2008","unstructured":"Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008;167:267\u201377.","journal-title":"Eur J Pediatr"},{"key":"604_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/mt.2010.32","volume":"18","author":"S Tomatsu","year":"2010","unstructured":"Tomatsu S, Monta\u00f1o AM, Dung VC, Ohashi A, Oikawa H, Oguma T, et al. Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome. Mol Ther. 2010;18:1094\u2013102.","journal-title":"Mol Ther"},{"key":"604_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","volume":"114","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Alm\u00e9ciga-D\u00edaz CJ, Monta\u00f1o AM, Yabe H, Tanaka A, Dung VC, et al. Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab. 2015;114:94\u2013109.","journal-title":"Mol Genet Metab"},{"key":"604_CR30","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/j.athoracsur.2016.02.113","volume":"102","author":"C Pizarro","year":"2016","unstructured":"Pizarro C, Davies RR, Theroux M, Spurrier EA, Averill LW, Tomatsu S. Surgical reconstruction for severe tracheal obstruction in Morquio A syndrome. Ann Thorac Surg. 2016;102:e329\u201331.","journal-title":"Ann Thorac Surg"},{"key":"604_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/hmg\/ddm353","volume":"17","author":"S Tomatsu","year":"2007","unstructured":"Tomatsu S, Montano AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2007;17:815\u201324.","journal-title":"Hum Mol Genet"},{"key":"604_CR32","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40262-014-0173-y","volume":"53","author":"Y Qi","year":"2014","unstructured":"Qi Y, Musson DG, Schweighardt B, Tompkins T, Jesaitis L, Shaywitz AJ, et al. Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome. Clin Pharm. 2014;53:1137\u201347.","journal-title":"Clin Pharm"},{"key":"604_CR33","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","volume":"67","author":"M Rohrbach","year":"2007","unstructured":"Rohrbach M, Clarke JTR. Treatment of lysosomal storage disorders: progress with enzyme replacement therapy. Drugs. 2007;67:2697\u2013716.","journal-title":"Drugs"},{"key":"604_CR34","first-page":"iii\u2013iv, ix","volume":"10","author":"M Connock","year":"2006","unstructured":"Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, et al. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry\u2019s disease and mucopolysaccharidosis type 1. Health Technol Assess. 2006;10:iii\u2013iv, ix\u2013113.","journal-title":"Health Technol Assess"},{"key":"604_CR35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1080\/21678707.2017.1366900","volume":"5","author":"Y Puckett","year":"2017","unstructured":"Puckett Y, Mulinder H, Monta\u00f1o AM. Enzyme replacement therapy with elosulfase alfa for mucopolysaccharidosis IVA (Morquio A syndrome): milestones and challenges. Expert Opin Orphan Drugs. 2017;5:741\u201352.","journal-title":"Expert Opin Orphan Drugs"},{"key":"604_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ymgmr.2016.10.001","volume":"9","author":"J Cao Do","year":"2016","unstructured":"Do Cao J, Wiedemann A, Quinaux T, Battaglia-Hsu SF, Mainard L, Froissart R, et al. 30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: about one case. Mol Genet Metab Rep. 2016;9:42\u20135.","journal-title":"Mol Genet Metab Rep"},{"key":"604_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1056\/NEJM200101183440304","volume":"344","author":"ED Kakkis","year":"2001","unstructured":"Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med. 2001;344:182\u20138.","journal-title":"N Engl J Med"},{"key":"604_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ymgme.2008.01.007","volume":"94","author":"AM Monta\u00f1o","year":"2008","unstructured":"Monta\u00f1o AM, Oikawa H, Tomatsu S, Nishioka T, Vogler C, Gutierrez MA, et al. Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice. Mol Genet Metab. 2008;94:178\u201389.","journal-title":"Mol Genet Metab"},{"key":"604_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","volume":"88","author":"T Nishioka","year":"2006","unstructured":"Nishioka T, Tomatsu S, Gutierrez MA, Miyamoto K, Trandafirescu GG, Lopez PLC, et al. Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. Mol Genet Metab. 2006;88:244\u201355.","journal-title":"Mol Genet Metab"},{"key":"604_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/10611860108997922","volume":"9","author":"T Sekido","year":"2001","unstructured":"Sekido T, Sakura N, Higashi Y, Miya K, Nitta Y, Nomura M, et al. Novel drug delivery system to bone using acidic oligopeptide: pharmacokinetic characteristics and pharmacological potential. J Drug Target. 2001;9:111\u201321.","journal-title":"J Drug Target"},{"key":"604_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2016.04.005","volume":"118","author":"E Yasuda","year":"2016","unstructured":"Yasuda E, Suzuki Y, Shimada T, Sawamoto K, Mackenzie WG, Theroux MC, et al. Activity of daily living for Morquio A syndrome. Mol Genet Metab. 2016;118:111\u201322.","journal-title":"Mol Genet Metab"},{"key":"604_CR42","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ymgme.2018.02.002","volume":"123","author":"K Nagao","year":"2018","unstructured":"Nagao K, Morlet T, Haley E, Padilla J, Nemith J, Mason RW, et al. Neurophysiology of hearing in patients with mucopolysaccharidosis type IV. Mol Genet Metab. 2018;123:472\u20138.","journal-title":"Mol Genet Metab"},{"key":"604_CR43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/pr.2015.169","volume":"78","author":"SA Jones","year":"2015","unstructured":"Jones SA, Bialer M, Parini R, Martin K, Wang H, Yang K, et al. Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y. Pediatr Res. 2015;78:717\u201322.","journal-title":"Pediatr Res"},{"issue":"S2","key":"604_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","volume":"44","author":"D Concolino","year":"2018","unstructured":"Concolino D, Deodato F, Parini R. Enzyme replacement therapy: efficacy and limitations. Ital J Pediatr. 2018;44(S2):120.","journal-title":"Ital J Pediatr"},{"key":"604_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ymgme.2014.08.012","volume":"114","author":"CJ Hendriksz","year":"2015","unstructured":"Hendriksz CJ, Giugliani R, Harmatz P, Mengel E, Guffon N, Valayannopoulos V, et al. Multi-domain impact of elosulfase alfa in Morquio A syndrome in the pivotal phase III trial. Mol Genet Metab. 2015;114:178\u201385.","journal-title":"Mol Genet Metab"},{"key":"604_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bone.2007.05.007","volume":"41","author":"H Oliver","year":"2007","unstructured":"Oliver H, Jameson KA, Sayer AA, Cooper C, Dennison EM, Hertfordshire Cohort Study Group the HCS. Growth in early life predicts bone strength in late adulthood: the Hertfordshire Cohort Study. Bone. 2007;41:400\u20135.","journal-title":"Bone"},{"key":"604_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","volume":"125","author":"SA Khan","year":"2018","unstructured":"Khan SA, Mason RW, Giugliani R, Orii K, Fukao T, Suzuki Y, et al. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Mol Genet Metab. 2018;125:44\u201352.","journal-title":"Mol Genet Metab"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0604-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0604-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-019-0604-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:23Z","timestamp":1684616843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-019-0604-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1038\/s10038-019-0604-6","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"12 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}